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Background: Like all medical innovations, telestroke must demonstrate successful
outcomes to achieve sustained growth and acceptance. Asserting that telemedicine
is faster, employs the latest technology, or promotes a better use of limited re-
sources is laudable but insufficient.An analysis of stroke treatment within a telemedicine
network in 2013 showed that tissue-type plasminogen activator (tPA) could be
safely and reliably administered within a practice-based model of telestroke care.
Since then, hospital volume and tPA administration within this network have tripled.
We hypothesize that a practice-based model of telestroke can maintain positive
outcomes in the face of rapid growth. Methods: Data on tPA treatment times and
outcomes after thrombolysis were gathered for 165 patients treated with alteplase
between November 2012 and November 2014. Comparisons were made to a pre-
vious published study of 54 patients seen between October 2010 and October 2012
in the same network. Primary outcome measures were average door-to-needle (DTN)
time for TPA administration and average call-to-needle (CTN) time. Results: Sig-
nificant reductions were observed in median DTN (93 versus 75 minutes, P < .01)
and median CTN (56 versus 41 minutes, P < .01). Quality outcome measures such
as post-tPA symptomatic hemorrhage (2 [4%] versus 9 [5%], P = .23), length of
stay (4 versus 4 days, P = .45), mortality (8 [15%] versus 16 [10%]; P = .32), and
percentage of stroke patients treated remained stable. Conclusions: This study shows
that a practice-based telemedicine system can produce meaningful improvement
in markers of telestroke efficiency in the face of rapid growth of a telestroke network.
Key Words: Call-to-needle (CTN) time—door-to-needle (DTN) time—stroke
mimic—telemedicine—telestroke—tissue-type plasminogen activator (tPA).
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Introduction
Early intravenous tissue-type plasminogen activator (tPA)
administration for acute ischemic stroke improves patient
outcomes in a highly time-dependent manner.1-3 Telestroke,
the application of telemedicine for rapid stroke diagno-
sis and treatment, facilitates tPA use by allowing a
neurologist to remotely evaluate a patient. The need for
high-quality telestroke care remains high and will rise
with recent demonstrations of the benefit of thrombec-
tomy in select stroke patients.4 While long a bastion of
academic centers, an analysis of telestroke in 2013 showed
that tPA could be safely and reliably administered within
a practice-based model of telestroke care.5 Since then, hos-
pital volume and tPA administration within this network
have tripled. We hypothesize that a practice-based model
of telemedicine can maintain positive outcomes in the face
of rapid growth and, in so doing, serve as a model for
continued improvement in stroke care.
Methods
AcuteCare Telemedicine’s (ACT) 4 practice-based neu-
rologists evaluated patients with neurological emergencies
using 2 commercially available telemedicine systems.6,7
Between November 1, 2012, and November 30, 2014,
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ACT’s network grew from 7 to 20 hospitals, ranging
from 35 to 420 beds. In these Georgia, Alabama, South
Carolina, and Tennessee hospitals, emergency room phy-
sicians initiated telemedicine consultations by phone to
obtain a telestroke consultation. Patients believed to
exhibit signs of acute stroke had telestroke video evalu-
ations. Data were extracted for all stroke patients treated
with tPA over the course of the study period.
We collected demographic information and phone re-
sponse time (time fromACT notification to emergency room
callback) from our database. We analyzed outcomes of tPA-
treated patients by reviewing discharge summaries and
associated hospital notes. Primary outcome measures were
the median door-to-needle (DTN) time for tPA adminis-
tration, the median call-to-needle (CTN) time, and final
diagnosis. DTN was calculated as the difference between
patient arrival time and tPA bolus time, whereas CTN was
defined as the span between the requesting physicians’ call
to ACT and the tPA bolus time. Secondary outcome mea-
sures included the door-to-call (DTC) time, onset-to-
needle (OTN) time, and call-to-response (CTR) time. DTC
was calculated as the window between patient arrival time
and the initial call to ACT. CTR, the portion of the DTN
window directly attributable to the telestroke service pro-
vider, is the span between the requesting physicians’ call
and ACT’s callback. OTN is the time window between the
documented stroke symptom onset and tPA bolus. The in-
vestigation was a retrospective analysis and patients’
information was anonymized and an institutional review
board exemption was obtained.
Comparisons between the 2 studies were evaluated using
the Wilcoxon rank sum test for continuous variables and
Fisher’s exact test for categorical variables. All P values
were 2-sided and P values less than .05 were considered
significant. Statistical analysis was performed using the
software SAS (version 9.3; the SAS Institute, Cary, NC).
Results
In the study period, ACT conducted 1653 phone con-
sultations leading to 706 video evaluations and 165 tPA
treatments. The demographic characteristics of the pa-
tients treated with intravenous tPA are outlined in Table 1
along with data from our first study. There was no sig-
nificant difference in patient demographics in this study
versus ACT’s first study: age, gender, National Institutes
of Health Stroke Scale (NIHSS) score, or any of the outcome
measures (hemorrhage, mortality, and length of stay). CTR
time did not change. Analysis of large versus small hos-
pitals and weekend versus weekday presentation revealed
no significant difference in treatment times or outcomes.
We saw a trend toward improved treatment time in all
individual hospitals. The average NIHSS score of tPA pa-
tients was 9.8. The symptomatic hemorrhage rate was 5%
and 57% of patients were discharged home.
Table 2 shows primary and secondary outcome mea-
sures. DTN was excluded in 23 patients (13.9%) with
invalid or missing arrival or treatment times. DTC was
excluded in 20 patients (12.1%) and CTN was excluded
in 4 patients (2.4%). ACT’s CTR was available for all
165 tPA patients. For the 165 patients who received
tPA, the median values of key time milestones were as
follows: OTN: 150 minutes (interquartile range [IQR],
115-175); DTN: 74.5 minutes (IQR, 55-97); CTN: 41 minutes
(IQR, 30-55); onset-to-door: 60 minutes (IQR, 40-88);
DTC: 31 minutes (IQR, 20-47); CTR: 1 minute (IQR, 1-1)
with 32% of tPA patients receiving treatment within 60
minutes of emergency department arrival. There were
statistically significant improvements in 3 time inter-
vals. Median DTN shortened from 93 to 75 minutes
between 2010-2012 and 2012-2014 (P < .01), median DTC
decreased from 38 to 31 minutes (P = .02), and median
CTN decreased from 56 to 41 minutes (P < .01). Figure 1
shows these improvements graphically.
Discussion
This study demonstrates meaningful improvement in
markers of telestroke efficiency in the face of rapid growth
of a telestroke network. Comparing our earlier data to
this new data set, we saw a statistically significant im-
provement in 3 time intervals leading to a total reduction
Table 1. Demographics and outcomes
Characteristics Study 1 (n = 54) Study 2 (n = 165) P value
Age, median (range) 59 (34, 92) 63 (23, 95) .64
Male, N (%) 30 (56) 87 (53) .76
NIHSS score, median (range) 8 (2, 26) 8 (2, 27) 1.00
Thrombectomy, N (%) 7 (13) 22 (14) 1.00
Length of stay (days), median (range) 4 (1, 18) 4 (1, 45) .45
In-hospital mortality, N (%) 8 (15) 16 (10) .32
Hemorrhage, N (%) 9 (17) 17 (10) .23
Symptomatic hemorrhage, N (%) 2 (4) 9 (5) 1.00
Stroke mimics, N (%) 8 (14.8) 23 (13.9) .826
Abbreviation: NIHSS, National Institutes of Health Stroke Scale.
IMPROVING TELESTROKE IN AN EXPANDING NETWORK 289
in treatment time of 18.5 minutes. The CTN improved
by 15 minutes and is attributable to both the telestroke
provider and hospital processes. However, hospital pro-
cesses benefitted independently after adoption of a
telestroke service, as represented by an improved DTC
time of 7 minutes. Quality outcome measures such as post-
tPA hemorrhage, length of stay, mortality, and treatment
of stroke percentages remained stable.
Despite the growth of the telestroke network, CTR did
not decline. Furthermore, these data suggest that partic-
ipation in a telestroke network for stroke care can help
hospitals improve their processes and ultimately their stroke
outcomes. Examination of telestroke outcomes provides
clear evidence of its value and shows that telestroke is
an important component of health-care systems’ efforts
to reduce DTN.4
Identifying the factors leading to improvement pro-
motes best telestroke practices.8 All of our hospitals showed
positive trends that support the power of cumulative ex-
perience and possibly an effect of their processes being
under close observation (i.e., the Hawthorne effect). One
might argue that as the telestroke system grew, it at-
tracted larger, better organized hospitals. Yet we did not
see a correlation between primary end points and hos-
pital size. Still, many of our hospitals are primary stroke
centers with active coordinators whose continuous work
undoubtedly improved stroke treatment processes and
outcomes. However, it is equally clear that several factors
are attributable directly to the telestroke providers, and
these factors are summarized in Table 3.
Some of our hospitals are in their sixth year of telestroke
and others have just started. A learning curve would
therefore apply to both the hospitals and telestroke pro-
viders; faster tPA treatment times result from more
experience. This was reported in a large recent Europe-
an study, but unlike the current study, they found that
smaller hospitals did not improve their treatment times.2
Further analysis of process and outcomes will include a
deeper look at the subintervals in the DTN: call-to-
decision, video-to-decision, and decision-to-treatment times.
To our knowledge, this is the first consistently re-
ported series of practice-based telestroke outcomes.
Table 2. Interval times
ACT tPA patients Patient cohort Mean Median Min Max STDEV P value
Symptom onset-to-door Second 68.4 60 0 221 43.9
Symptom OTN Second 149 150 60 268 45.3
CTR Second 2.1 1 0 43 3.8 .098
First 2.9 2 0 30 4.5
DTC Second 36.3 31 0 153 24.9 .02
First 44.2 38 2 149 26.2
DTN Second 81 74.5 29 220 32.8 <.01
First 104.6 93 47 269 39.5
CTN Second 45 41 0 129 22.8 <.01
First 60.3 56 14 170 31.2
Abbreviations: CTN, call-to-needle; CTR, call-to-response; DTC, door-to-call; DTN, door-to-needle; OTN, onset-to-needle; STDEV, stan-
dard deviation.
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Figure 1. DTN components shown in stacked
chronological order for 2010-2012 and 2012-
2014. Abbreviations: CTN, call-to-needle; DTN,
door-to-needle.
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Asserting that telemedicine is faster, employs the latest
technology, or promotes a better use of limited re-
sources is laudable but insufficient. Like all medical
innovations, telestroke must demonstrate successful out-
comes and improved care to achieve sustained growth
and acceptance. This study demonstrates that and serves
as support for increased utilization of telestroke and
perhaps telemedicine in general. Poor response times and
physician burnout adversely affect care. A desultory rollout
of telestroke, without attention to those factors listed in
Table 3, will lead to hospital, physician, and patient
dissatisfaction.
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Table 3. How telestroke providers improve stroke care
Process Rationale
Communication Early direct communication between hospital staff and the teleneurologist by phone then
video reduces CTN.
Staffing A limited staff of teleneurologists engenders familiarity and a level of trust from the ER
doctors, which streamlines communication.
Quality improvement Investment of teleneurologists in the quality improvement process as partners with the
hospitals improves standards.
Reinforcing Telestroke providers approaching each call as an opportunity to reinforce the hospital’s
stroke care processes with ER doctors and nursing staff leads to enhanced learning.
Regional expertise engagement Transfer of eligible patients for thrombectomy requires an understanding of and engagement
with comprehensive stroke centers.
Sharing outcomes Sharing of outcome measures should include all members of the telestroke network team:
providers and hospital alike.
Abbreviations: CTN, call-to-needle; ER, emergency room.
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